BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6252497)

  • 1. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Endorphin-induced stimulation of central sympathetic outflow: inhibitory modulation by central noradrenergic neurons.
    Appel NM; Van Loon GR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):695-701. PubMed ID: 2940358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Endorphin-induced stimulation of central sympathetic outflow: beta-endorphin increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats.
    Van Loon GR; Appel NM; Ho D
    Endocrinology; 1981 Jul; 109(1):46-53. PubMed ID: 6263592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-opiate beta-endorphin fragments and dopamine-V. gamma-Type endorphins and prolactin secretion in rats.
    Lamberts SW; de Quijada M; Van Ree JM; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1129-35. PubMed ID: 6184642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Endorphin alters dopamine uptake by the dopamine neurons of the hypothalamus and striatum.
    George SR; Van Loon GR
    Brain Res; 1982 Sep; 248(2):293-303. PubMed ID: 6291701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-endorphin-induced decrease in hypothalamic dopamine turnover.
    van Loon GR; Ho D; Kim C
    Endocrinology; 1980 Jan; 106(1):76-80. PubMed ID: 7349975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for an inhibitory action of blood-borne beta-endorphin on LH release.
    Malven PV
    J Reprod Fertil Suppl; 1987; 34():9-16. PubMed ID: 2957499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic inhibition of pituitary beta-endorphin-like immunoreactivity secretion in the rat.
    Farah JM; Malcolm DS; Mueller GP
    Endocrinology; 1982 Feb; 110(2):657-9. PubMed ID: 6276143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal modulation of central dopaminergic transmission.
    Drago F; Scapagnini U
    J Neural Transm Suppl; 1986; 22():47-54. PubMed ID: 3023550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tiapride infusion on plasma levels of beta-endorphin, prolactin and dopamine in patients with pain from cancer.
    Gennari C; Nami R; Pizzuti M; D'Ascenzo G; Bianchini C
    Pathol Biol (Paris); 1981 Feb; 29(2):105-10. PubMed ID: 6262702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholaminergic control of intracellular free calcium and beta-endorphin secretion of rat pituitary intermediate lobe cells.
    Némethy Z; Horváth G; Makara GB; Acs Z; Barna I
    J Neuroendocrinol; 1998 Feb; 10(2):85-91. PubMed ID: 9535054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of beta-endorphin on catecholamine levels in the rat hypothalamus and cerebral cortex].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV
    Biull Eksp Biol Med; 1986 May; 101(5):562-4. PubMed ID: 2939890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of tiapride infusion on plasma levels of beta-endorphin, prolactin and dopamine in patients with pain from cancer (author's transl)].
    Gennari C; Nami R; Pizzuti M; D'Ascenzo G; Bianchini C
    Sem Hop; 1981 Apr 18-25; 57(15-16):795-800. PubMed ID: 6269192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic and dopaminergic regulation of circulating beta-endorphin-like immunoreactivity in hypertension.
    Alföldi A; Simkó K; Fekete MI; Farsang C
    Acta Physiol Hung; 1991; 78(1):99-106. PubMed ID: 1763654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic agents in the treatment of hyperprolactinemia].
    Mornex R; Hugues B
    J Pharmacol; 1983; 14 Suppl 3():81-103. PubMed ID: 6369001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro.
    Nijkamp FP; van Ree JM; Nijssen JG; Versluis M; de Wied D
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):213-7. PubMed ID: 6185856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased opiate action of beta-endorphin in iron-deficient rats: the possible involvement of dopamine.
    Yehuda S; Youdim MB
    Eur J Pharmacol; 1984 Sep; 104(3-4):245-51. PubMed ID: 6094214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does beta-endorphin modulate basal and dopamine-inhibited prolactin release by an action at the anterior pituitary?
    Cheung CY
    Neuroendocrinology; 1984 Dec; 39(6):489-95. PubMed ID: 6096753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.